208 related articles for article (PubMed ID: 32909849)
1. Synthesis of PEGylated nanographene oxide as a nanocarrier for docetaxel drugs and anticancer activity on prostate cancer cell lines.
Tas A; Keklikcioglu Cakmak N
Hum Exp Toxicol; 2021 Jan; 40(1):172-182. PubMed ID: 32909849
[TBL] [Abstract][Full Text] [Related]
2. Graphene oxide-wrapped PEGylated liquid crystalline nanoparticles for effective chemo-photothermal therapy of metastatic prostate cancer cells.
Thapa RK; Youn YS; Jeong JH; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2016 Jul; 143():271-277. PubMed ID: 27022866
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
Chen Y; Xu Z; Lu T; Luo J; Xue H
Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107
[TBL] [Abstract][Full Text] [Related]
4. LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs Docetaxel and Quercetin for prostate cancer.
Shitole AA; Sharma N; Giram P; Khandwekar A; Baruah M; Garnaik B; Koratkar S
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111035. PubMed ID: 32994029
[TBL] [Abstract][Full Text] [Related]
5. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
[TBL] [Abstract][Full Text] [Related]
6. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
[TBL] [Abstract][Full Text] [Related]
7. An effective strategy for development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer.
Thambiraj S; Vijayalakshmi R; Ravi Shankaran D
Sci Rep; 2021 Feb; 11(1):2808. PubMed ID: 33531521
[TBL] [Abstract][Full Text] [Related]
8. Docetaxel encapsulation in nanoscale assembly micelles of folate-PEG-docetaxel conjugates for targeted fighting against metastatic breast cancer in vitro and in vivo.
Andisheh F; Oroojalian F; Shakour N; Ramezani M; Shamsara J; Khodaverdi E; Nassirli H; Hadizadeh F; Alibolandi M
Int J Pharm; 2021 Aug; 605():120822. PubMed ID: 34182039
[TBL] [Abstract][Full Text] [Related]
9. GO-PEG as a drug nanocarrier and its antiproliferative effect on human cervical cancer cell line.
Bikhof Torbati M; Ebrahimian M; Yousefi M; Shaabanzadeh M
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):568-573. PubMed ID: 27027552
[TBL] [Abstract][Full Text] [Related]
10. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells.
Eloy JO; Ruiz A; de Lima FT; Petrilli R; Raspantini G; Nogueira KAB; Santos E; de Oliveira CS; Borges JC; Marchetti JM; Al-Jamal WT; Chorilli M
Colloids Surf B Biointerfaces; 2020 Oct; 194():111185. PubMed ID: 32574928
[TBL] [Abstract][Full Text] [Related]
11. Preparation, characterization, and in vitro evaluation of docetaxel-loaded poly(lactic acid)-poly(ethylene glycol) nanoparticles for parenteral drug delivery.
Liu D; Wang L; Liu Z; Zhang C; Zhang N
J Biomed Nanotechnol; 2010 Dec; 6(6):675-82. PubMed ID: 21361132
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Sadeghian-Rizi S
Anticancer Agents Med Chem; 2018; 18(14):2017-2031. PubMed ID: 30205803
[TBL] [Abstract][Full Text] [Related]
13. Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo.
Yan J; Wang Y; Zhang X; Liu S; Tian C; Wang H
Drug Deliv; 2016 Jun; 23(5):1757-62. PubMed ID: 26203689
[TBL] [Abstract][Full Text] [Related]
14. A novel intracellular pH-responsive formulation for FTY720 based on PEGylated graphene oxide nano-sheets.
Masoudipour E; Kashanian S; Maleki N; Karamyan A; Omidfar K
Drug Dev Ind Pharm; 2018 Jan; 44(1):99-108. PubMed ID: 28956455
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro characterization, and anti-tumor effects of novel polystyrene-poly(amide-ether-ester-imide) co-polymeric micelles for delivery of docetaxel in breast cancer in Balb/C mice.
Varshosaz J; Enteshari S; Hassanzadeh F; Hashemi-Beni B; Minaiyan M; Mirsafaei R
Drug Dev Ind Pharm; 2018 Jul; 44(7):1139-1157. PubMed ID: 29436875
[TBL] [Abstract][Full Text] [Related]
16. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic synthesis of PEGylated lactide-diester-diol copolyesters for highly efficient targeted anticancer drug delivery.
Su M; Xie J; Zeng Q; Shu M; Liu J; Jiang Z
Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111125. PubMed ID: 32600724
[TBL] [Abstract][Full Text] [Related]
18. Novel pH-sensitive charge-reversal cell penetrating peptide conjugated PEG-PLA micelles for docetaxel delivery: in vitro study.
Ouahab A; Cheraga N; Onoja V; Shen Y; Tu J
Int J Pharm; 2014 May; 466(1-2):233-45. PubMed ID: 24614579
[TBL] [Abstract][Full Text] [Related]
19. Docetaxel gold complex nanoflowers: A chemo-biological evaluation for their use as nanotherapeutics.
Haddada MB; Movia D; Prina-Mello A; Spadavecchia J
Colloids Surf B Biointerfaces; 2020 Oct; 194():111172. PubMed ID: 32534368
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
